tiprankstipranks
Atara Biotherapeutics Inc (ATRA)
NASDAQ:ATRA
US Market
ATRA
Atara Biotherapeutics
RESEARCH TOOLSreports
Want to see ATRA full AI Analyst Report?

Atara Biotherapeutics (ATRA) Stock News & Sentiment

1,201 Followers
Atara Biotherapeutics Faces Securities Lawsuit After FDA Setbacks and Sharp Stock Declines Tied to Tabelecleucel 
Premium
Class Action
Atara Biotherapeutics Faces Securities Lawsuit After FDA Setbacks and Sharp Stock Declines Tied to Tabelecleucel 
11d ago
ATRA
Atara Biotherapeutics Faces Federal Securities Lawsuit Over Alleged Misstatements About Drug Approval Prospects
Premium
Class Action
Atara Biotherapeutics Faces Federal Securities Lawsuit Over Alleged Misstatements About Drug Approval Prospects
1M ago
ATRA
Atara Plans FDA Type A Meeting on EBVALLO
Premium
Company Announcements
Atara Plans FDA Type A Meeting on EBVALLO
2M ago
8K
ATRA
Atara, Pierre Fabre seek FDA meeting on EBVALLO
Premium
Company Announcements
Atara, Pierre Fabre seek FDA meeting on EBVALLO
2M ago
8K
ATRA
ATRA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ATRA Earnings this Week: How Will it Perform?
2M ago
ATRA
Atara Biotherapeutics Extends Royalty Milestone, Issues Warrant
Premium
Company Announcements
Atara Biotherapeutics Extends Royalty Milestone, Issues Warrant
2M ago
8K
ATRA
Tabelecleucel’s Phase 3 EBV+ PTLD Trial Progress Signals Continued Potential for Atara Biotherapeutics
Premium
Company Announcements
Tabelecleucel’s Phase 3 EBV+ PTLD Trial Progress Signals Continued Potential for Atara Biotherapeutics
3M ago
ATRA
More ATRA News >

ATRA News on the Web

Atara Biotherapeutics Faces Securities Lawsuit After FDA Setbacks and Sharp Stock Declines Tied to Tabelecleucel
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) and Rezolute (RZLT)
TipRanks News
Neutral
Atara Biotherapeutics Faces Federal Securities Lawsuit Over Alleged Misstatements About Drug Approval Prospects
TipRanks News
Bearish
Atara Biotherapeutics files to sell 400K shares of common stock for holders
TipRanks News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Atara Biotherapeutics (ATRA), DocGo (DCGO) and Gilead Sciences (GILD)
TipRanks News
Bearish
Atara provides update on tabelecleucel biologics license application
TipRanks News
Neutral
Atara Plans FDA Type A Meeting on EBVALLO
TipRanks News
Bearish
Atara Biotherapeutics Secures Type A FDA Meeting for Tabelecleucel: Regulatory Path Forward in Focus
Market Chameleon
Neutral

News Score - Last 7 Days

Neutral
ATRA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATRA’s Media Buzz Sentiment?
1 articles about ATRA were published this week. In an average week, 1 articles are published.
    What is ATRA’s weekly average amount of articles?
    In an average week, 1 articles about ATRA are published.
      What is ATRA’s News Sentiment?
      50% of articles about ATRA were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week